Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

Lowie Vanfleteren,1–3 Leonardo M Fabbri,1,4 Alberto Papi,4 Stefano Petruzzelli,5 Bartolome Celli6 1COPD Center, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden; 2CIRO, Horn, the Netherlands; 3Department of Respiratory Medicine, Maastric...

Full description

Bibliographic Details
Published in:	International Journal of COPD
Main Authors:	Vanfleteren L, Fabbri LM, Papi A, Petruzzelli S, Celli B
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-12-01
Subjects:	Muscarinic antagonists adrenergic beta-2 receptor agonists glucocorticoids pulmonary disease chronic obstructive review exacerbations safety
Online Access:	https://www.dovepress.com/triple-therapy-icslabalama-in-copd-time-for-a-reappraisal-peer-reviewed-article-COPD

Similar Items

Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA
by: Vicente Plaza, et al.
Published: (2023-11-01)

Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD
by: Strange C, et al.
Published: (2019-06-01)

Comparing Costs and Healthcare Resource Utilization (HCRU) Using LAMA versus LABA/ICS at Treatment Initiation for COPD: Findings from CITRUS (Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea) Study
by: Choi KY, et al.
Published: (2024-07-01)

Overactive bladder – 18 years – part I
by: Jose Carlos Truzzi, et al.
Published: (2016-04-01)

Overactive bladder – 18 years – Part II
by: Jose Carlos Truzzi, et al.
Published: (2016-04-01)

Normalisation of airflow limitation in asthma: Post‐hoc analyses of TRIMARAN and TRIGGER
by: Alberto Papi, et al.
Published: (2022-04-01)

Treatment Persistence and Adherence with Overactive Bladder Medications in Taiwan: A Retrospective Database Analysis
by: Shiau-Han Chen, et al.
Published: (2026-06-01)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
by: Halpin DMG, et al.
Published: (2017-10-01)

Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box
by: Lowie E.G.W. Vanfleteren, et al.
Published: (2019-02-01)

Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD
by: Albertson TE, et al.
Published: (2019-06-01)

AM/PM dosing of LAMA for COPD: a randomized controlled trial protocol using digital recruitment and registries
by: Pradeesh Sivapalan, et al.
Published: (2024-08-01)

Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework
by: Chun-Yu Chen, et al.
Published: (2023-09-01)

MODERN POSSIBILITIES OF MEDICAL TREATMENT OF OVERACTIVE BLADDER IN WOMEN
by: I. A. Apolikhina, et al.
Published: (2017-12-01)

Risk Factors of Local Oropharyngeal and Laryngeal Adverse Effects from Use of Single Inhaled Corticosteroids and Long-Acting Beta-Agonists
by: Nobuyuki Horita, et al.
Published: (2012-01-01)

Cognitive Function and Urologic Medications for Lower Urinary Tract Symptoms
by: Yeon Joo Kim, et al.
Published: (2020-09-01)

Effectiveness of ICS/LABA and LAMA/LABA in COPD due to biomass
by: Alejandra Ramírez-Venegas, et al.
Published: (2024-11-01)

Long-acting Bronchodilators in COPD Management: One or Two?
by: Konstantinos Kostikas, et al.
Published: (2023-01-01)

Experience of using double bronchodilation therapy in patients with COPD
by: I. V. Demko, et al.
Published: (2021-01-01)

Relaxant effect of Curcuma longa on rat tracheal smooth muscle and its possible mechanisms
by: Bahman Emami, et al.
Published: (2017-01-01)

The medical management of glaucoma
by: André Marais, et al.
Published: (2017-05-01)

Airway Deposition of Extrafine Inhaled Triple Therapy in Patients with COPD: A Model Approach Based on Functional Respiratory Imaging Computer Simulations
by: Usmani OS, et al.
Published: (2020-10-01)

COPD from an everyday primary care point of view
by: Antonio L Aguilar-Shea, et al.
Published: (2019-01-01)

Use of Beta-Blockers as a First-Line Treatment for Primary Hypertension
by: Maryam Izadi, et al.
Published: (2024-10-01)

Patterns of bronchodilator therapy in asthmatic outpatients
by: Toetik Aryani, et al.
Published: (2023-03-01)

Pathophysiology, Therapeutic Targets, and Future Therapeutic Alternatives in COPD: Focus on the Importance of the Cholinergic System
by: Felisbela Gomes, et al.
Published: (2023-03-01)

New Aspects of 2-Adrenergic Agonists
by: Touseef Sayyar
Published: (2015-12-01)

Inhaled LAMA in the management of asthma: when to add an anticholinergic versus increase inhaled corticosteroid dose
by: Rafał Pawliczak
Published: (2025-05-01)

Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies
by: Martinez FJ, et al.
Published: (2020-01-01)

24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD
by: Colin Reisner, et al.
Published: (2017-08-01)

Understanding Chronic Obstructive Pulmonary Disease Management and Treatment Patterns in General Medicine: Results From the ASTER Study in Italy
by: Genga G, et al.
Published: (2025-09-01)

Prevalencia de autoanticuerpos contra receptores autonómicos en pacientes panameños con cardiopatía chagásica crónica y con otras formas de cardiopatía
by: Azael Saldaña, et al.
Published: (2009-03-01)

Benefit of dual bronchodilator therapy on exacerbations in former and current smokers with chronic obstructive pulmonary disease in real-world clinical practice: a multicenter validation study (TOReTO)
by: Yu-Ting Lai, et al.
Published: (2024-10-01)

Relationship of inhaled long-acting bronchodilators with cardiovascular outcomes among patients with stable COPD: a meta-analysis and systematic review of 43 randomized trials
by: Li CX, et al.
Published: (2019-04-01)

Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials
by: Gary T. Ferguson, et al.
Published: (2020-05-01)

Standardized ileal digestible lysine in diets for pigs fed ractopamine in commercial production system
by: Alysson Saraiva, et al.
Published: (2017-11-01)

Standardized ileal digestible lysine in diets for pigs fed ractopamine in commercial production system
by: Alysson Saraiva, et al.
Published: (2017-11-01)

Pyogenic Granuloma Treated with Topical Timolol: A Case Series
by: Manjeet Naresh Ramteke, et al.
Published: (2023-10-01)

Atenolol prevents the formation of expansive hematoma after rhytidoplasty
by: Amanda Castilho Moreira, et al.

Hypertension and Male Fertility
by: David Guo, et al.
Published: (2017-08-01)

LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes
by: Hizawa N
Published: (2015-06-01)